1,123 material Form 8-K filings that 897 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Federal Realty reported third-quarter 2025 results on October 31, 2025. FFO per diluted share rose to $1.77 from $1.71, while net income available for common shareholders per diluted share slipped to $0.69 from $0.70. The company raised its low-end 2025 FFO guidance and narrowed its ranges, and reported a 2025 earnings per share range of $3.93 to $3.99.
Q3 2025 FFO per diluted share was $1.77, up from $1.71 in Q3 2024, an increase of 3.5%.
Q3 2025 net income available for common shareholders per diluted share was $0.69, versus $0.70 a year earlier.
2025 FFO per diluted share guidance is now $7.20 to $7.26, up from $7.16 to $7.26 at the low end.
Q3 2025 operating income was $110.7 million, compared with $105.8 million in Q3 2024.
Interface reported third-quarter 2025 GAAP diluted earnings per share of $0.78, up 62.5% year over year, and adjusted diluted EPS of $0.61, up 27.1%. The company raised its full-year 2025 net sales outlook to $1.375 billion to $1.390 billion, from $1.370 billion to $1.390 billion, and its adjusted gross profit margin outlook to 38.5% from 37.7%. Both headline results and guidance moved higher for shareholders.
Q3 2025 net sales were $364.5 million, up 5.9% year over year and up 4.2% on a currency-neutral basis.
GAAP net income for the quarter was $46.1 million, up 62.2%, and diluted EPS was $0.78 versus $0.48 a year earlier.
Full-year 2025 net sales outlook raised to $1.375 billion to $1.390 billion; adjusted gross profit margin outlook raised to 38.5% of net sales.
Cash rose to $187.4 million at September 28, 2025, from $99.2 million at December 29, 2024, and net debt fell to $120.4 million.
Xenia Hotels & Resorts reported a third-quarter 2025 net loss attributable to common stockholders of $13.7 million, or $0.14 per share, compared with a net loss of $7.1 million, or $0.07 per share, a year earlier. Adjusted EBITDAre fell 4.6% to $42.2 million, and the company lowered the high end of its full-year 2025 guidance, which matters to shareholders because it reduces the expected range of earnings and cash flow for the year.
Q3 2025 net loss attributable to common stockholders was $13.7 million, or $0.14 per share, versus a net loss of $7.1 million, or $0.07 per share, in Q3 2024
Q3 Adjusted EBITDAre of $42.2 million decreased 4.6%; Adjusted FFO per diluted share of $0.23 decreased 8.0%
Full-year 2025 Adjusted EBITDAre guidance is $250 million to $258 million, with the high end cut by $5 million from prior guidance
Same-Property RevPAR guidance for 2025 is a 3.50% to 4.50% increase; the high end was reduced by 1.00%
Cousins Properties reported third quarter 2025 results and raised its full-year 2025 FFO guidance to $2.82 to $2.86 per share from $2.79 to $2.85. Q3 FFO rose to $116.5 million, or $0.69 per share, from $102.3 million, or $0.67 per share, a year earlier, but GAAP net income available to common stockholders fell to $8.6 million, or $0.05 per share, from $11.2 million, or $0.07 per share.
Q3 2025 FFO was $116.5 million, or $0.69 per share, versus $102.3 million, or $0.67 per share, in Q3 2024.
Q3 2025 net income available to common stockholders was $8.6 million, or $0.05 per share, versus $11.2 million, or $0.07 per share, in Q3 2024.
2025 FFO guidance was raised to $2.82 to $2.86 per share from $2.79 to $2.85; net income guidance is $0.30 to $0.34 per share, up from $0.28 to $0.34.
The company acquired The Link, a 292,000 square foot office property in Uptown Dallas, for $218.0 million on July 28, 2025.
Healthcare Realty reported third-quarter 2025 Normalized FFO of $0.41 per share, up from $0.39 a year earlier, and a GAAP net loss of $0.17 per share, narrower than the $0.26 loss in the prior-year quarter. The company raised its 2025 Normalized FFO per share guidance to $1.59-$1.61 and same store cash NOI growth guidance to 4.00%-4.75%, while third-quarter revenue of $297.8 million was below the $315.4 million reported a year earlier.
Normalized FFO per share was $0.41 in Q3 2025 versus $0.39 in Q3 2024; NAREIT FFO was $0.34 versus $0.21.
GAAP net loss attributable to common stockholders was $57.7 million ($0.17 per share) versus $93.0 million ($0.26 per share) a year earlier.
Total revenues were $297.8 million versus $315.4 million in Q3 2024.
2025 guidance: Normalized FFO per share raised to $1.59-$1.61 from $1.57-$1.61; same store cash NOI growth raised to 4.00%-4.75% from 3.25%-4.00%. The board approved a $0.24 per share dividend payable November 21, 2025.
The Bancorp reported third-quarter 2025 net income of $54.9 million, or $1.18 per diluted share, up from $1.04 a year earlier, with share buybacks cutting outstanding shares 8%. The company lowered its 2025 EPS guidance to $5.10 from $5.25, citing lower projected traditional lending balances and higher leasing credit provisions tied to trucking losses, which matters for shareholders expecting the earlier outlook.
Q3 2025 net income of $54.9 million, or $1.18 diluted EPS, versus $51.5 million, or $1.04, in Q3 2024
2025 EPS guidance lowered to $5.10 from $5.25, due to lower projected lending balances and a higher leasing credit provision tied to trucking losses
No specific 2026 guidance; company targets a minimum $7 EPS run-rate by Q4 2026 and gave preliminary 2027 EPS guidance of $8.25
Shares repurchased totaled 2,034,053 at an average $73.74 in Q3; outstanding shares fell to 44.5 million from 48.2 million
VICI Properties reported third-quarter 2025 results with total revenues up 4.4% year-over-year to $1.0 billion and AFFO attributable to common stockholders up 7.4% to $637.6 million. The company raised the low end of its full-year 2025 AFFO guidance to between $2,510 million and $2,520 million, or $2.36 to $2.37 per diluted share, and announced a lease agreement for MGM Northfield Park with an affiliate of Clairvest.
Net income attributable to common stockholders rose 4.0% to $762.0 million, or $0.71 per share, though a $11.5 million change in the CECL allowance partly offset the increase.
AFFO per share rose 5.3% to $0.60 for the quarter, and the quarterly dividend was set at $0.45 per share, a 4.0% increase.
Full-year 2025 AFFO guidance was updated to $2,510 million to $2,520 million, compared with prior guidance of $2,500 million to $2,520 million.
The Northfield Park lease carries an initial annual base rent of $53.0 million, or $54.0 million if closing occurs on or after May 1, 2026, and is expected to close in the first half of 2026.
Republic Services reported third-quarter 2025 net income of $550 million, or $1.76 per diluted share, down from $1.80 a year earlier, while revenue rose to $4.21 billion from $4.08 billion. The company said 2025 revenue is expected to be near the low end of its updated full-year range of $16.675 billion to $16.750 billion, which means shareholders should expect the top line to finish toward the lower end of that range.
Q3 2025 net income was $550 million, or $1.76 per diluted share, versus $566 million, or $1.80, in Q3 2024.
Adjusted EPS was $1.90 versus $1.81 a year earlier; the company recorded a $56 million labor disruption impact in the quarter.
Revenue was $4,212 million for the quarter, up 3.3 percent from $4,076 million.
The company reiterated all other components of its 2025 guidance and declared a $0.625 quarterly dividend payable January 15, 2026.
AMETEK reported third quarter 2025 sales of $1.89 billion, up 11% from a year earlier, and adjusted earnings of $1.89 per diluted share, up 14%. The company raised its full-year 2025 adjusted earnings per share guidance to $7.32 to $7.37 from $7.06 to $7.20, which matters to shareholders because it signals higher expected profit for the year.
Q3 2025 GAAP diluted EPS was $1.60, up from $1.47 in Q3 2024; adjusted EPS was $1.89, up from $1.66.
2025 adjusted EPS guidance raised to $7.32 to $7.37 from $7.06 to $7.20; overall sales still expected up mid-single digits versus 2024.
Q4 2025 adjusted EPS expected at $1.90 to $1.95, and overall sales expected up about 10% versus Q4 2024.
Acquisition-related pre-tax costs of $19.7 million ($0.07 per diluted share) were tied to the FARO Technologies acquisition in Q3.
Dream Finders Homes reported third-quarter 2025 results with homebuilding revenue down 7% to $917 million and net income attributable to the company down to $47 million from $71 million. It also cut its full-year 2025 outlook to approximately 8,500 home closings from a prior outlook of approximately 9,250, citing challenging market conditions.
Q3 homebuilding revenues were $917 million, down 7% from $986 million, while home closings rose 1% to 1,915.
Net income attributable to DFH was $47 million, or $0.47 per basic share, versus $71 million, or $0.72 per basic share a year earlier.
Full-year 2025 home closings guidance was revised to approximately 8,500 from approximately 9,250.
The company issued $300 million of 6.875% senior unsecured notes and had total liquidity of $625 million as of September 30, 2025.
IDACORP reported third quarter 2025 net income of $124.4 million, or $2.26 per diluted share, up from $113.6 million, or $2.12 per diluted share, a year earlier. The company raised its full-year 2025 earnings guidance to $5.80 to $5.90 per diluted share from $5.70 to $5.85, and said it reached a constructive settlement of its Idaho general rate case, which is pending approval by the Idaho Public Utilities Commission.
Q3 2025 net income attributable to IDACORP was $124.4 million, or $2.26 per diluted share, versus $113.6 million, or $2.12, in Q3 2024.
Nine-month 2025 net income was $279.9 million, or $5.13 per diluted share, versus $251.3 million, or $4.82, in the same period of 2024.
Full-year 2025 EPS guidance rose to $5.80 to $5.90 from $5.70 to $5.85, assuming normal weather and power supply expenses for the rest of 2025.
Idaho general rate case settlement is pending approval by the Idaho Public Utilities Commission.
APi Group reported third-quarter 2025 net revenues of $2.1 billion, up 14.2% from a year earlier, and net income of $93 million, up 34.8%. The company raised its full-year 2025 guidance for net revenues and adjusted EBITDA, which signals higher expected results for shareholders.
Q3 2025 net revenues were $2,085 million, up 14.2% (9.7% organic), versus $1,826 million a year earlier
Q3 net income was $93 million and diluted EPS was $0.20, compared with $69 million and $0.15 in Q3 2024
Full-year 2025 net revenue guidance raised to $7,825 to $7,925 million from $7,650 to $7,850 million
Full-year 2025 adjusted EBITDA guidance set at $1,015 to $1,045 million, up from $1,005 to $1,045 million
Cushman & Wakefield reported third-quarter 2025 revenue of $2.6 billion, up 11% from a year earlier, and net income of $51.4 million, compared with $33.7 million. It raised its full-year 2025 adjusted EPS growth guidance to 30%-35%, up from 25%-35%, and prepaid an additional $100 million of term loan debt on October 29, 2025. Equity method earnings fell $20.7 million, mainly due to a $46.1 million non-cash loan loss provision at the Greystone JV, of which the company recorded $18.5 million.
Q3 2025 revenue of $2.6 billion rose 11%; service line fee revenue of $1.8 billion rose 9%
Diluted EPS was $0.22 versus $0.14; adjusted diluted EPS was $0.29 versus $0.23
Full-year 2025 adjusted EPS growth guidance raised to 30%-35% from 25%-35%
Prepaid $100 million on October 29, 2025, bringing 2025 year-to-date prepayments to $300 million
L3Harris reported third-quarter 2025 revenue of $5.7 billion, up 7% from a year earlier, and GAAP diluted EPS of $2.46, up 17%. The company raised its 2025 guidance, lifting non-GAAP diluted EPS to $10.50-$10.70 from $10.40-$10.60 and revenue to about $22 billion from about $21.75 billion. Cash from operations fell 30% to $546 million, which the company attributed to temporary customer payment delays.
Third-quarter revenue $5.659 billion, up 7% (10% organic); GAAP operating margin 11.0% vs 9.4%
Non-GAAP diluted EPS $2.70, up 10%; GAAP diluted EPS $2.46, up from $2.10
2025 non-GAAP diluted EPS guidance raised to $10.50-$10.70; revenue guidance raised to about $22 billion
Cash from operations $546 million, down 30%; adjusted free cash flow $449 million, down 38%
DT Midstream reported third quarter 2025 net income of $115 million, or $1.13 per diluted share, and Adjusted EBITDA of $288 million. The company raised its 2025 Adjusted EBITDA guidance to $1,115 million to $1,145 million and declared a quarterly dividend of $0.82 per share, which matters to shareholders because it reflects higher expected earnings and a continued dividend payout.
Q3 2025 net income was $115 million, or $1.13 per diluted share, up from $107 million, or $1.04 per share, in Q2 2025
Adjusted EBITDA was $288 million for Q3 2025, compared with $277 million in Q2 2025
2025 Adjusted EBITDA guidance raised to $1,115 million to $1,145 million; 2026 early outlook reaffirmed at $1,155 million to $1,225 million
Quarterly dividend of $0.82 per share, payable January 15, 2026 to holders of record on December 15, 2025
CMS Energy reported third-quarter 2025 diluted EPS of $0.92, up from $0.84 a year earlier, and adjusted EPS of $0.93 versus $0.84. The company raised its 2025 adjusted EPS guidance to $3.56 to $3.60 from $3.54 to $3.60 and initiated 2026 adjusted EPS guidance of $3.80 to $3.87, which gives shareholders updated earnings expectations for both years.
Q3 2025 operating revenue was $2,021 million, compared with $1,743 million in Q3 2024; net income available to common stockholders was $275 million, compared with $251 million.
Year-to-date adjusted EPS was $2.66, compared with $2.47 a year earlier, which the company attributed largely to constructive regulatory outcomes and favorable weather.
The company reaffirmed long-term adjusted EPS growth of 6% to 8%, with continued confidence toward the high end, and will host a webcast on October 30 at 9:30 a.m. ET.
Vontier reported third-quarter 2025 sales of $752.5 million, up 0.3% from a year earlier, with GAAP diluted EPS of $0.70 versus $0.60 and adjusted diluted EPS of $0.78 versus $0.73. The company raised its full-year 2025 adjusted diluted EPS guidance to $3.15 to $3.20 and set a fourth-quarter range of $0.82 to $0.86, though Repair Solutions sales fell 6.9%.
Q3 2025 sales were $752.5 million, up 0.3%; core sales were flat year over year
GAAP diluted EPS was $0.70 vs. $0.60 a year earlier; adjusted diluted EPS was $0.78 vs. $0.73
Full-year 2025 adjusted diluted EPS guidance raised to $3.15 to $3.20; Q4 2025 guidance is $0.82 to $0.86
Repair Solutions sales declined 6.9% to $141.6 million; company repurchased about $175 million of shares year-to-date
Advance Auto Parts reported third-quarter 2025 results for the period ended October 4, 2025. Net sales fell to $2.0 billion from $2.1 billion a year earlier, while comparable store sales rose 3.0% and adjusted diluted EPS improved to $0.92 from a loss of $0.05. The company narrowed its full-year 2025 guidance and reaffirmed the midpoint of its comparable sales and adjusted operating margin expectations.
Q3 net sales were $2.0 billion versus $2.1 billion a year earlier; comparable store sales increased 3.0%.
Q3 GAAP diluted EPS from continuing operations was $(0.02) versus $(0.42); adjusted diluted EPS was $0.92 versus $(0.05).
Full-year 2025 adjusted diluted EPS guidance is $1.75 to $1.85, versus a prior range of $1.20 to $2.20.
Full-year 2025 net sales guidance is $8,550 million to $8,600 million, including $100 million to $120 million from a 53rd week.
Amneal reported third-quarter 2025 net revenue of $785 million, up 12% from $702 million a year earlier, and GAAP net income attributable to the company of $2 million, or $0.01 per diluted share, compared with a loss in the prior-year quarter. The company raised its 2025 adjusted EBITDA, adjusted diluted EPS and operating cash flow guidance and left net revenue guidance unchanged, while a $31.4 million loss on refinancing weighed on quarterly results.
Net revenue was $785 million, up 12%; Specialty rose 8%, Affordable Medicines rose 8% and AvKARE rose 24%.
GAAP net income attributable to Amneal was $2 million ($0.01 per diluted share); adjusted diluted EPS was $0.17, up 6% from $0.16.
2025 adjusted diluted EPS guidance was raised to $0.75-$0.80 from $0.70-$0.75, and adjusted EBITDA guidance to $675-$685 million from $665-$685 million.
The quarter included a $31.4 million loss on refinancing tied to the August 1, 2025 borrowing of $2.1 billion in term loans and $600 million of senior notes due 2032.
Biogen reported third-quarter 2025 total revenue of $2.5 billion, up 3%, and non-GAAP diluted EPS of $4.81, up 18% from a year earlier. It lowered full-year 2025 non-GAAP diluted EPS guidance to $14.50 to $15.00 from $15.50 to $16.00 in July, citing an expected impact of about ($1.25) per share from business development transactions expected to close in the fourth quarter, partly offset by a $0.25 benefit from its outlook. For shareholders, quarterly results rose while expected full-year earnings per share fell.
Q3 2025 total revenue was $2,535 million, up 3% year over year; GAAP diluted EPS was $3.17, up 19%; non-GAAP diluted EPS was $4.81, up 18%.
Full-year 2025 non-GAAP diluted EPS guidance is $14.50 to $15.00, down from $15.50 to $16.00 in July (October 2025 update).
The EPS guidance cut reflects an approximately ($1.25) impact from business development transactions expected to close in Q4 2025, partly offset by a $0.25 benefit from a stronger business outlook.
Full-year 2025 total revenue guidance was raised to approximately flat to increasing 1% at constant currency, up from approximately flat.
WESCO International reported third-quarter 2025 net sales of $6.2 billion, up 12.9% from a year earlier, and raised its full-year 2025 outlook for organic sales growth and adjusted EPS. Reported diluted EPS was $3.79, down 0.5%, and the company reduced its full-year free cash flow outlook because of higher working capital.
Q3 net sales of $6.2 billion, up 12.9%; organic sales up 12.1%; data center sales of $1.2 billion, up about 60%
Adjusted diluted EPS of $3.92, up 9.5%; GAAP diluted EPS of $3.79 versus $3.81, down 0.5%
Full-year organic sales growth outlook raised to 8% to 9% from 5% to 7%; adjusted EPS outlook set at $13.10 to $13.60
Full-year free cash flow outlook reduced; Q3 free cash flow was negative $89.3 million
KBR reported third quarter fiscal 2025 results on October 30, 2025, with revenue of $1.9 billion, down $6 million, while net income attributable to KBR rose to $115 million and Adjusted EBITDA rose 10% to $240 million. The company lowered its fiscal 2025 revenue guidance to $7.75 billion-$7.85 billion from $7.9 billion-$8.1 billion, citing the pace of awards and bids won under protest that will not be resolved during the U.S. Government shutdown. For shareholders, higher profit is offset by a lower revenue forecast, while the Adjusted EBITDA, Adjusted EPS and operating cash flow guidance was unchanged.
Q3 revenue was $1,931 million, down $6 million from $1,937 million in the prior-year quarter.
Net income attributable to KBR was $115 million versus $100 million; diluted EPS was $0.90 versus $0.75.
Adjusted EBITDA was $240 million, up 10%, and Adjusted EPS was $1.02, up 21%.
Fiscal 2025 revenue guidance was cut to $7.75 billion-$7.85 billion; Adjusted EBITDA ($960 million-$980 million), Adjusted EPS ($3.78-$3.88) and operating cash flows ($500 million-$550 million) were unchanged.
Essex Property Trust reported third-quarter 2025 Core FFO of $3.97 per diluted share, up 1.5% from $3.91 a year earlier and $0.03 above the midpoint of its guidance range. Net income per diluted share rose to $2.56 from $1.84, mainly due to gains on sale of real estate, and the company raised its full-year 2025 Core FFO and net income guidance midpoints.
Q3 2025 Core FFO per diluted share $3.97 vs. $3.91 in Q3 2024; nine-month Core FFO $11.96 vs. $11.68
Q3 2025 net income per diluted share $2.56 vs. $1.84; nine-month Total FFO per share $12.03 vs. $12.30, down 2.2%
Full-year 2025 Core FFO guidance raised $0.03 at midpoint to $15.89 to $15.99; net income guidance raised $0.41 at midpoint to $10.53 to $10.63
Q3 2025 same-property revenue grew 2.7% and NOI grew 2.4% year over year; earnings call set for October 30, 2025 at 11 a.m. PT
Silgan reported third quarter 2025 net sales of $2.01 billion, up 15%, and diluted EPS of $1.06, up from $0.93, with adjusted EPS of $1.22, up 1%. The company cut its full-year 2025 adjusted EPS estimate to $3.66 to $3.76 from $3.85 to $4.05, citing lower customer volume forecasts in North American personal and home care and higher tax and interest expense, which weighs on shareholder earnings expectations despite the stronger quarter.
Q3 2025 net sales $2.01 billion, up $263.6 million (15%) from $1.75 billion, driven mainly by the Weener acquisition and higher raw material pass-through costs
Q3 2025 net income $113.3 million, or $1.06 per diluted share, versus $100.1 million, or $0.93, a year earlier; adjusted EPS $1.22 versus $1.21
2025 adjusted EPS estimate lowered to $3.66 to $3.76 from $3.85 to $4.05; Q4 2025 adjusted EPS estimate of $0.62 to $0.72 versus $0.85 in Q4 2024
Company confirmed 2025 free cash flow estimate of $430 million and raised 2025 interest expense estimate to about $190 million from about $185 million
Ventas reported third-quarter 2025 results with normalized FFO of $0.88 per share, up 10% from $0.80 a year earlier, and net income attributable to common stockholders of $66.0 million, versus $19.2 million in the prior-year quarter. The company raised its full-year 2025 guidance for normalized FFO per share to a range of $3.45 to $3.48 from $3.41 to $3.46, and lifted its senior housing investment volume expectation to $2.5 billion from $2.0 billion.
Q3 2025 total revenues were $1.49 billion, up from $1.24 billion in Q3 2024.
Q3 2025 same-store cash NOI for the senior housing operating portfolio (SHOP) grew 16% year over year, with same-store cash NOI margin up 200 basis points.
Full-year 2025 normalized FFO per share guidance midpoint rose to $3.47 from $3.44 as of July 30, 2025.
Net debt to further adjusted EBITDA improved to 5.3x at September 30, 2025, a 1.0x improvement from Q3 2024.
Encompass Health reported third-quarter 2025 net operating revenue of $1,477.5 million, up 9.4% from a year earlier, and adjusted earnings per share of $1.23, up from $1.03. The company raised its full-year 2025 guidance for adjusted EBITDA and adjusted EPS, and its revenue range was narrowed. Adjusted free cash flow fell 8.2% in the quarter, to $174.2 million.
Q3 2025 diluted EPS from continuing operations was $1.24, up from $1.07; adjusted EPS was $1.23, up from $1.03.
Q3 adjusted EBITDA was $300.1 million, up 11.4% from $269.3 million; adjusted free cash flow was $174.2 million, down from $189.7 million.
Full-year 2025 adjusted EPS guidance rose to $5.22 to $5.37 from $5.12 to $5.34; adjusted EBITDA guidance rose to $1,235 million to $1,255 million from $1,220 million to $1,250 million.
Full-year 2025 net operating revenue guidance was narrowed to $5,905 million to $5,955 million from $5,880 million to $5,980 million.
Rush Street Interactive reported third-quarter 2025 revenue of $277.9 million, up 20% from a year earlier, and net income of $14.8 million, up from $3.2 million. It also raised its full-year 2025 revenue and Adjusted EBITDA guidance, which matters to shareholders because it signals higher expected results for the year.
Q3 revenue was $277.9 million, up 20% from $232.1 million in Q3 2024.
Q3 net income was $14.8 million versus $3.2 million; diluted EPS was $0.06 versus $0.01.
Adjusted EBITDA was $36.0 million, up 54% from $23.4 million.
2025 revenue guidance was raised to $1.1 billion to $1.12 billion, and Adjusted EBITDA guidance to $147 million to $153 million.
American Homes 4 Rent (AMH) reported third quarter 2025 results on October 29, 2025, with rents and other single-family property revenues up 7.5% year-over-year to $478.5 million and net income attributable to common shareholders of $99.7 million, or $0.27 per diluted share, versus $0.20 a year earlier. The company raised the midpoint of its full year 2025 Core FFO guidance by $0.01 per share to $1.87, which matters to shareholders because it signals higher expected per-share operating earnings for the year.
Q3 2025 rents and other single-family property revenues rose 7.5% to $478.5 million, from $445.1 million in Q3 2024.
Net income attributable to common shareholders was $99.7 million, or $0.27 per diluted share, versus $73.8 million, or $0.20, in Q3 2024.
Core FFO was $0.47 per share and unit, up 6.2% year-over-year; Adjusted FFO was $0.42, up 9.1%.
Full year 2025 Core FFO guidance is now $1.86 to $1.88 per share, up from $1.84 to $1.88, with the midpoint raised to $1.87.
Mid-America Apartment Communities (MAA) reported third-quarter 2025 results with diluted earnings per share of $0.84, down from $0.98, and Core FFO per diluted share of $2.16, down from $2.21. It lowered its full-year 2025 earnings per share guidance to $4.18 to $4.30 from $5.25 to $5.49, and narrowed its Core FFO guidance to $8.68 to $8.80 from $8.65 to $8.89, which lowers the midpoint to $8.74 from $8.77.
Q3 2025 diluted EPS was $0.84 versus $0.98 in Q3 2024; Core FFO per diluted share was $2.16 versus $2.21.
Revised full-year 2025 EPS guidance is $4.18 to $4.30 (midpoint $4.24), down from $5.25 to $5.49 (midpoint $5.37).
Q3 2025 rental and other property revenues were $554.4 million, up from $551.1 million a year earlier.
The board declared its 127th consecutive quarterly common dividend, paid October 31, 2025; the current annual dividend rate is $6.06 per share.
Independence Realty Trust reported third quarter 2025 net income available to common shares of $6.9 million, down from $12.4 million a year earlier, with EPS of $0.03 versus $0.05. Core Funds from Operations (CFFO) rose to $70.0 million, and CFFO per share held at $0.29, but the company lowered its full-year 2025 EPS guidance to $0.27 to $0.28 from $0.475 to $0.535, while FFO and CFFO per share guidance midpoints were unchanged.
Q3 2025 net income available to common shares was $6.9 million versus $12.4 million in Q3 2024; EPS was $0.03 versus $0.05.
Q3 2025 CFFO was $70.0 million versus $66.8 million; CFFO per share was $0.29 in both periods.
2025 EPS guidance is now $0.27 to $0.28, down from $0.475 to $0.535; the company said the change reflects fewer gains on sale from lower disposition volume.
Same-store NOI grew 2.7% in Q3 2025, and same-store occupancy at quarter end was 95.6%.
Waystar reported third-quarter 2025 revenue of $268.7 million, up 12% year over year, and net income of $30.6 million, or $0.17 per diluted share, compared with $5.4 million, or $0.03, a year earlier. The company also raised its full-year 2025 revenue and adjusted EBITDA guidance, which signals management's confidence in the rest of the year.
Q3 revenue was $268.7 million, up from $240.1 million in Q3 2024.
Q3 net income was $30.6 million, or $0.17 per diluted share, versus $5.4 million, or $0.03, a year earlier.
Full-year 2025 revenue guidance is $1.085 billion to $1.093 billion, and adjusted EBITDA guidance is $451 million to $455 million, both raised.
Q3 non-GAAP net income was $67.8 million, or $0.37 per diluted share.
Oshkosh reported third-quarter 2025 net income of $196.2 million, or $3.04 per diluted share, up from $2.75 a year earlier, though sales fell 1.9% to $2.69 billion. The company lowered its 2025 adjusted earnings per share outlook to $10.50 to $11.00, down $0.50 at the low end, and cut its net sales expectation to $10.3 billion to $10.4 billion from $10.6 billion, which matters to shareholders because the lower outlook reflects weaker expected sales volume in the Transport and Access segments.
Q3 net income was $196.2 million, or $3.04 per diluted share, versus $2.75 a year earlier; results include a $0.30 per share benefit from resolving a multi-year U.S. federal income tax audit.
Q3 sales decreased $52.8 million, or 1.9%, to $2.69 billion, mainly due to lower Access segment sales volume.
2025 adjusted EPS outlook is $10.50 to $11.00, down $0.50 from prior guidance on the low end; net sales outlook is $10.3 billion to $10.4 billion versus $10.6 billion previously.
Board declared a quarterly cash dividend of $0.51 per share, payable December 1, 2025 to shareholders of record as of November 17, 2025.
Vita Coco reported third-quarter 2025 results on October 29, 2025, with net sales up 37% to $182 million and net income of $24 million, or $0.40 per diluted share, compared with $19 million and $0.32 a year earlier. The company raised its full-year 2025 net sales guidance to $580 million to $595 million and its adjusted EBITDA guidance to $90 million to $95 million, although gross margin fell to 38% from 39%.
Q3 net sales were $182 million, up 37%, with Vita Coco Coconut Water net sales up 42%.
Q3 net income was $24 million ($0.40 diluted EPS) versus $19 million ($0.32); adjusted EBITDA was $32 million versus $23 million.
Full-year 2025 guidance: net sales of $580 million to $595 million and adjusted EBITDA of $90 million to $95 million.
Gross margin was 38% versus 39%, reflecting higher finished goods and tariff costs; the company reported no debt and $204 million in cash as of September 30, 2025.
Fortive reported third-quarter 2025 revenue of $1.03 billion, up 2.3% year over year, with adjusted diluted EPS of $0.68, up 15.3%. The company raised its full-year 2025 adjusted diluted EPS guidance to $2.63 to $2.67 from $2.50 to $2.60, and executed $1 billion of share repurchases, about 6% of diluted shares outstanding. Operating cash flow and free cash flow declined in the quarter, and the GAAP net earnings figure of $55 million reflects a $62 million loss from discontinued operations.
Q3 2025 revenue was $1.03 billion, up 2.3%; core revenue rose 1.9%
GAAP diluted EPS was $0.35, up 9.4%; adjusted diluted EPS was $0.68, up 15.3%
Full-year 2025 adjusted diluted EPS guidance raised to $2.63 to $2.67 from $2.50 to $2.60
Share repurchases totaled $1 billion, comprising 21 million shares
Verisk reported third-quarter 2025 revenue of $768 million, up 5.9%, and diluted EPS of $1.61, up 4.5%. It lowered its full-year 2025 total revenue outlook to $3,050–$3,080 million from the $3,090–$3,130 million range it set in July, and kept its diluted adjusted EPS outlook at $6.80–$7.00. The FTC also issued a Second Request on the pending AccuLynx acquisition.
Q3 revenue of $768 million, up 5.9% (5.5% on an organic constant currency basis); the CFO cited a historically low level of severe weather that reduced growth by about 1%.
Diluted EPS of $1.61, up 4.5%; diluted adjusted EPS of $1.72, up 3.0%.
Full-year 2025 total revenue outlook lowered to $3,050–$3,080 million from $3,090–$3,130 million in July.
On October 22, 2025, Verisk and AccuLynx each received an FTC Second Request on the proposed transaction.
Kraft Heinz reported third-quarter 2025 net sales of $6.2 billion, down 2.3% from a year earlier, and adjusted EPS of $0.61, down 18.7%. The company lowered its full-year 2025 guidance for organic net sales and constant currency adjusted operating income, and narrowed its adjusted EPS range to $2.50 to $2.57, which lowers the top end of the prior $2.51 to $2.67 range. For shareholders, the weaker outlook and higher costs point to lower near-term earnings, though free cash flow rose 23.3%.
Q3 2025 net sales fell 2.3% to $6.2 billion; organic net sales fell 2.5%, with volume/mix down 3.5 percentage points
Q3 adjusted operating income fell 16.9% to $1.1 billion; diluted EPS was $0.52 versus a loss of $0.24 a year earlier, which reflected prior-year impairment losses
Full-year 2025 constant currency adjusted operating income now expected down 10% to 12%, versus the prior down 5% to 10%
Year-to-date free cash flow was $2.5 billion, up 23.3%; the separation into two companies remains on track for the second half of 2026
Generac reported third-quarter 2025 net sales down 5% to $1.11 billion and net income of $66 million, or $1.12 per diluted share, versus $1.89 a year earlier. The company lowered its full-year 2025 net sales growth guidance to approximately flat, citing a significantly weaker power outage environment that reduced seasonal generator demand. Shareholders face a weaker outlook than previously guided, with full-year adjusted EBITDA margin now expected at about 17.0%.
Third-quarter net sales fell 5% to $1.11 billion from $1.17 billion; residential product sales fell about 13% to $627 million.
Third-quarter diluted EPS was $1.12 versus $1.89 a year earlier; net income was $66 million versus $114 million.
Full-year 2025 net sales growth guidance was lowered to approximately flat, from the prior range of an increase of 2% to 5%; adjusted EBITDA margin is now expected at about 17.0%, versus 18.0% to 19.0% previously.
Dana reported third-quarter 2025 sales of $1.92 billion from continuing operations, up from $1.90 billion a year earlier, and net income of $13 million compared with a net loss of $21 million. The company raised its full-year profit guidance, citing accelerated cost savings, and said the Off-Highway divestiture remains on track to close in late 2025.
Q3 adjusted EBITDA was $162 million, or 8.5 percent of sales, compared with $111 million, or 5.9 percent, a year earlier
Full-year 2025 adjusted EBITDA guidance for continuing operations is $570 million to $610 million; sales guidance is $7.3 billion to $7.5 billion
Dana repurchased $189 million of shares in Q3 and expects to repurchase $155 million more in Q4, bringing the 2025 total to $600 million
Cost savings were $73 million in Q3 and $183 million year to date, with $235 million expected for 2025
Urban Edge Properties reported third-quarter 2025 net income attributable to common shareholders of $14.9 million, up from $9.1 million a year earlier, and raised its full-year 2025 guidance. The company also said it acquired Brighton Mills Shopping Center in Massachusetts for $39 million, adding to its Boston-area holdings.
Q3 2025 net income attributable to common shareholders was $14,935 thousand, or $0.12 per diluted share, versus $9,080 thousand, or $0.07, in Q3 2024.
Q3 2025 FFO as Adjusted per diluted share was $0.36, compared with $0.35 a year earlier.
2025 FFO as Adjusted guidance is now $1.42 to $1.44 per diluted share, with a midpoint of $1.43, up from $1.42.
On October 23, 2025, the company acquired Brighton Mills Shopping Center for a gross purchase price of $39 million.
Hormel Foods expects fourth-quarter adjusted earnings per share about $0.08 to $0.09 below its prior expectations, and it is not reaffirming its GAAP EPS guidance range pending year-end closing, with non-cash impairment charges expected mainly in its International segment and snack nuts business. Net sales growth is expected toward the top end of its guidance range. Chief Financial Officer Jacinth Smiley is leaving, and Paul Kuehneman was named interim CFO and controller effective October 27, 2025.
Adjusted EPS expected about $0.08 to $0.09 below prior expectations for the fiscal fourth quarter ended October 26, 2025.
GAAP EPS guidance range not reaffirmed; non-cash impairment charges expected, primarily in International and snack nuts.
Net sales growth expected toward the top end of the previously issued guidance range.
Jacinth Smiley no longer CFO effective October 26, 2025, and remains employed until November 30, 2025; a Little Rock peanut butter plant fire is being repaired, with full production expected early in fiscal 2026.
Otis reported third quarter 2025 net sales of $3.7 billion, up 4%, with organic sales up 2%. Service sales rose 9%, while New Equipment sales fell 4%, and the company raised the midpoint of its 2025 adjusted EPS outlook to $4.04 to $4.08. GAAP EPS fell 29% to $0.95 because of a non-recurring tax benefit in the prior-year quarter, but adjusted EPS rose 9% to $1.05.
Q3 2025 net sales of $3.7 billion, up 4%; organic sales up 2%
Q3 adjusted EPS of $1.05, up 9%; GAAP EPS of $0.95, down 29%
2025 adjusted EPS outlook of $4.04 to $4.08, up 5 to 7%, with the midpoint raised
Q3 Service net sales up 9%; New Equipment net sales down 4%, with China down about 20%
Kadant reported third quarter 2025 revenue of $271.6 million, flat with the prior year, while net income fell 12% to $27.7 million and diluted GAAP EPS fell to $2.35 from $2.68. The company raised its 2025 revenue guidance to $1.036 billion to $1.046 billion but cut its 2025 GAAP EPS guidance to $8.52 to $8.72, and kept adjusted EPS guidance at $9.05 to $9.25.
Q3 2025 revenue was $271.6 million, flat versus $271.6 million in Q3 2024; organic revenue fell 4%.
Q3 adjusted EBITDA fell 8% to $58.0 million, and adjusted EBITDA margin was 21.4% versus 23.3%.
2025 revenue guidance raised to $1.036 billion to $1.046 billion from $1.020 billion to $1.040 billion.
2025 GAAP EPS guidance cut to $8.52 to $8.72 from $8.89 to $9.09; adjusted EPS guidance maintained at $9.05 to $9.25.
Jack Henry & Associates reported $8.6 million of deconversion revenue for the fiscal first quarter ended September 30, 2025, and raised its full-year fiscal 2026 deconversion revenue estimate to $20 million. The filing covers only this revenue line, not total revenue or earnings, and the company says deconversion revenue is excluded from its non-GAAP revenue because it mainly arises when a client is acquired by another institution.
Fiscal Q1 2026 (quarter ended September 30, 2025) deconversion revenue was $8.6 million.
Full-year fiscal 2026 deconversion revenue estimate increased to $20 million.
Most deconversion revenue comes from clients being acquired by another financial institution, which ends their contract with Jack Henry.
Deconversion revenue is excluded from non-GAAP revenue in quarterly and annual earnings releases.
BrightSpring Health Services reported third-quarter 2025 revenue of $3,334 million, up 28.2% from a year earlier, and Adjusted EBITDA of $160 million, up 37.2%. The company raised its full-year 2025 revenue guidance and reiterated its Adjusted EBITDA guidance, which matters to shareholders because the headline sales and profit measures both improved.
Q3 2025 revenue was $3,334 million, up 28.2% from $2,601 million; continuing-operations net income was $37.5 million versus a net loss of $25.7 million a year earlier.
Adjusted EBITDA was $160 million, up 37.2% from $117 million.
2025 revenue guidance was raised to $12,500 million to $12,800 million; Adjusted EBITDA guidance of $605 million to $615 million was reiterated.
The planned sale of the Community Living business to Sevita is expected to close in Q1 2026.
W. P. Carey reported third-quarter 2025 revenues of $431.3 million, up 8.5% from a year earlier, and net income attributable to the company of $141.0 million, up 26.2%. The company raised and narrowed its full-year 2025 AFFO guidance to $4.93 to $4.99 per diluted share, citing higher expected investment volume, which matters to shareholders because AFFO is the company's main per-share earnings measure.
Q3 2025 revenues of $431.3 million, up 8.5% from $397.4 million in Q3 2024
Diluted EPS of $0.64 versus $0.51; AFFO of $1.25 per diluted share versus $1.18
2025 AFFO guidance raised and narrowed to $4.93 to $4.99 per diluted share, based on investment volume of $1.8 billion to $2.1 billion
Quarterly cash dividend of $0.910 per share, a 4.0% increase over the 2024 third quarter
EXL reported third-quarter 2025 results, with revenue up 12.2% year over year to $529.6 million and GAAP diluted EPS up 10.7% to $0.36. The company raised its full-year 2025 guidance for both revenue and adjusted diluted EPS, which points to stronger expected growth for shareholders, though operating income margin slipped to 14.4% from 14.7% a year earlier.
Q3 revenue of $529.6 million, up from $472.1 million in Q3 2024 (12.2% reported growth)
GAAP diluted EPS of $0.36 vs. $0.33 a year earlier; adjusted diluted EPS of $0.48 vs. $0.44
2025 revenue guidance raised to $2.07 billion to $2.08 billion; adjusted diluted EPS guidance raised to $1.88 to $1.92
Operating income margin of 14.4%, down from 14.7% in Q3 2024; conference call set for October 29, 2025 at 10:00 A.M. ET
Universal Health Services reported third-quarter 2025 net revenues up 13.4% to $4.495 billion and diluted EPS of $5.86, versus $3.80 a year earlier, and raised its full-year 2025 forecast for net revenues, Adjusted EBITDA net of NCI and Adjusted EPS-diluted. The board also added $1.5 billion to the stock repurchase authorization, bringing the available total to $1.759 billion, which matters to shareholders because it raises both the earnings outlook and the capacity for share buybacks.
Q3 2025 net income attributable to UHS was $373.0 million, or $5.86 per diluted share, versus $258.7 million, or $3.80, in Q3 2024
Q3 results included $90 million of pre-tax Medicaid reimbursements for Washington, D.C. and a $35 million pre-tax charge for professional and general liability reserves
2025 Adjusted EPS-diluted forecast raised to $21.50-$22.10 from $20.00-$21.00; net revenues forecast raised to $17.306-$17.445 billion
Board authorized a $1.5 billion increase to the stock repurchase program on October 27, 2025; 1.315 million shares repurchased in Q3 2025 for about $234.3 million
Repligen reported third-quarter 2025 revenue of $189 million, up 22% from $155 million a year earlier, and GAAP net income of $15 million versus a $1 million loss in the prior-year quarter. The company raised its full-year 2025 revenue guidance to $729 million to $737 million, and GAAP diluted EPS guidance is $0.82 to $0.85.
Q3 2025 revenue was $189 million, up 22% as reported and 18% organic, with no COVID-related revenue in either period.
GAAP diluted EPS was $0.26 versus a loss of $0.01 a year earlier; adjusted diluted EPS was $0.46 versus $0.43.
Full-year 2025 revenue guidance was increased to $729 million to $737 million, with GAAP diluted EPS guidance of $0.82 to $0.85.
Cash and cash equivalents were $749 million at September 30, 2025, compared with $757 million at December 31, 2024.
Incyte reported third-quarter 2025 total revenues of $1.37 billion, up 20% from a year earlier, and GAAP net income of $424.2 million, or $2.11 per diluted share, compared with $106.5 million, or $0.54 per diluted share, in the prior-year quarter. The company raised its full-year 2025 net product revenue guidance to $4.23-$4.32 billion, while reiterating its guidance for cost of product revenues, R&D and SG&A expenses.
Total revenues were $1.37 billion, up 20%; total net product revenues were $1.15 billion, up 19%.
GAAP diluted EPS was $2.11 versus $0.54 a year earlier; GAAP net income was $424.2 million versus $106.5 million.
Jakafi net product revenue rose 7% to $791 million; Opzelura rose 35% to $188 million.
Full-year 2025 net product revenue guidance was raised to $4.23-$4.32 billion, from the prior range that the filing lists for Jakafi and other oncology products.
A. O. Smith reported third-quarter 2025 net sales of $942.5 million, up 4%, and diluted EPS of $0.94, up 15% from $0.82 a year earlier. The company lowered its full-year 2025 sales outlook to flat to up 1% and narrowed its diluted EPS range to $3.70 to $3.85, with management citing China headwinds and weaker new home construction in North America, which matters to shareholders because the outlook is weaker even as recent results grew.
Q3 2025 net sales of $942.5 million, up 4%; net earnings of $132.0 million, up 10%; diluted EPS of $0.94, up 15%
Full-year 2025 consolidated sales now projected flat to up 1% versus 2024 actual of $3,818 million
Diluted EPS outlook narrowed to $3.70 to $3.85, with the midpoint lowered according to the CEO; 2024 diluted EPS was $3.63
China sales fell 12% in local currency in the quarter; board approved a 6% dividend increase on October 13, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.